🔴 20/20 Biolabs is trading 6.22% down today as yields and inflation pressure biotech

20/20 Biolabs is trading 6.22% down now at $0.40, with the move appearing primarily sector-driven amid broader biotech weakness.

• The decline extends the September 23 slide from $0.47.
• No company-specific announcement dated September 23 or September 24 was identified on the company’s investor-relations page, and no listed announcement directly explains the decline.
• Higher Treasury yields, elevated oil prices, and inflation concerns are pressuring growth-oriented healthcare stocks.